Clinical Application Expansion
Scar Assessment, Non-Melanoma Skin Cancer, Inflammatory Skin Diseases
Evidence GenerationActive
Key Facts
Indication
Scar Assessment, Non-Melanoma Skin Cancer, Inflammatory Skin Diseases
Phase
Evidence Generation
Status
Active
Company
About Michelson Diagnostics
Michelson Diagnostics is a pioneer and world leader in applying Optical Coherence Tomography (OCT) to dermatology through its flagship VivoSight Dx system. The company, founded by a team of physicists and engineers, has established strong clinical validation with its technology cited in hundreds of peer-reviewed publications. It operates as a commercial-stage, revenue-generating private company, targeting both the clinical dermatology and skin research markets with a direct sales and support model. Michelson's strategy centers on deepening the utility of OCT imaging in skin health, from scar assessment to non-melanoma skin cancer management.
View full company profile